Cagrilintide 10mg

Cagrilintide is a long-acting, acylated synthetic analog of human amylin (islet amyloid polypeptide)

Cagrilintide is a long-acting, acylated synthetic analog of human amylin (islet amyloid polypeptide). Amylin is a peptide hormone co-secreted with insulin by pancreatic beta cells. In laboratory research settings, Cagrilintide is investigated for its ability to activate amylin receptors, which are implicated in the regulation of gastric emptying, glucagon secretion, and satiety signaling. Scientific literature is currently focused on Cagrilintide’s potential synergistic effects when used in conjunction with GLP-1 receptor agonists. Research models frequently explore its efficacy in inducing weight loss and improving metabolic parameters through non-selective agonism of calcitonin gene-related peptide (CGRP) receptors and specific amylin receptor subtypes.

For research and educational purposes. Not intended for human consumption. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.